RETROGRADE DELIVERY OF SDF-1 FOR TREATMENT OF MYOCARDIAL INFARCTION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160024521A1
SERIAL NO

14773984

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are methods of treating a subject with a cardiomyopathy by administering to the subject's heart, via percutaneous retrograde coronary sinus perfusion, a pharmaceutical composition that comprises a DNA plasmid encoding SDF-1 and a pharmaceutically acceptable carrier or diluent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JUVENTAS THERAPEUTICS INC3615 SUPERIOR AVENUE SUITE 4403C CLEVELAND OH 44114

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ARAS, Rahul Broadview Hight, US 11 46
FISHER, Scott J Solon, US 1 1
PASTORE, Joseph Mentor, US 20 127
PENN, Marc S Beachwood, US 38 258

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation